Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionFAD - First Trust Multi Cap Growth AlphaDEX Fund
Latest Disclosed Ownership12,945 shares
Latest Disclosed Value $ 364,142
FAD - First Trust Multi Cap Growth AlphaDEX Fund reports 25.79% decrease in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On June 23, 2026 - FAD - First Trust Multi Cap Growth AlphaDEX Fund filed a NPORT-P form disclosing ownership of 12,945 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $364,143 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 25, 2026 disclosing 17,444 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of -25.79% during the quarter. The current value of the position is $407,638 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-23 2026-04-30 NP CATALYST PHARMACEUTICALS INC COM EC US14888U1016 12,945 -4,499 -25.79 364 -13.95 0.0758
2026-03-25 2026-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 17,444 12,950 288.16 424 345.26 0.1041
2025-12-23 2025-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 4,494 -5,685 -55.85 96 -56.22 0.0265
2025-09-24 2025-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 10,179 -2,764 -21.36 217 -30.89 0.0722
2025-06-25 2025-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 12,943 4,719 57.38 314 69.73 0.1276
2025-03-25 2025-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 8,224 -2,786 -25.30 186 -22.92 0.0776
2024-12-23 2024-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 11,010 1,132 11.46 240 41.18 0.1117
2024-09-23 2024-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 9,878 766 8.41 170 24.09 0.0813
2024-06-25 2024-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 9,112 -1,512 -14.23 137 -9.87 0.0755
2024-03-21 2024-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 10,624 3,620 51.68 153 76.74 0.0882
2023-12-27 2023-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 7,004 371 5.59 87 -5.49 0.0576
2023-09-27 2023-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 6,633 -3,746 -36.09 92 -44.85 0.0509
2023-06-28 2023-04-28 NP Catalyst Pharmaceuticals EC US14888U1016 10,379 10,379 165 0.0998
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.